La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !
Dynavax Technologies Bilan de santé
Santé financière contrôle des critères 4/6
Dynavax Technologies possède un total de capitaux propres de $642.8M et une dette totale de $223.3M, ce qui porte son ratio d'endettement à 34.7%. Son actif total et son passif total sont $1.0B et de $373.5M.
Informations clés
34.7%
Ratio d'endettement
US$223.27m
Dette
| Ratio de couverture des intérêts | n/a |
| Argent liquide | US$735.61m |
| Fonds propres | US$642.85m |
| Total du passif | US$373.47m |
| Total des actifs | US$1.02b |
Mises à jour récentes de la santé financière
Is Dynavax Technologies (NASDAQ:DVAX) Weighed On By Its Debt Load?
Jul 12
Is Dynavax Technologies (NASDAQ:DVAX) A Risky Investment?
Mar 06These 4 Measures Indicate That Dynavax Technologies (NASDAQ:DVAX) Is Using Debt Safely
Aug 02We Think Dynavax Technologies (NASDAQ:DVAX) Can Manage Its Debt With Ease
May 03Dynavax Technologies (NASDAQ:DVAX) Seems To Use Debt Rather Sparingly
Jan 16Is Dynavax Technologies (NASDAQ:DVAX) A Risky Investment?
Sep 12Recent updates
Some May Be Optimistic About Dynavax Technologies' (NASDAQ:DVAX) Earnings
Aug 14Is Dynavax Technologies (NASDAQ:DVAX) Weighed On By Its Debt Load?
Jul 12Lacklustre Performance Is Driving Dynavax Technologies Corporation's (NASDAQ:DVAX) Low P/S
May 22Dynavax: HEPLISAV-B Growth Up, Pipeline Uncertain
May 10Dynavax: Holding Firm Despite Its Missing Cash Cow
Mar 23Is Dynavax Technologies (NASDAQ:DVAX) A Risky Investment?
Mar 06Dynavax Technologies Corporation's (NASDAQ:DVAX) Business And Shares Still Trailing The Industry
Jan 31These 4 Measures Indicate That Dynavax Technologies (NASDAQ:DVAX) Is Using Debt Safely
Aug 02Improved Earnings Required Before Dynavax Technologies Corporation (NASDAQ:DVAX) Shares Find Their Feet
Jun 02We Think Dynavax Technologies (NASDAQ:DVAX) Can Manage Its Debt With Ease
May 03Dynavax Technologies (NASDAQ:DVAX) Seems To Use Debt Rather Sparingly
Jan 16Clover, Dynavax COVID-19 vaccine gets EU GMP certificate
Sep 20Is Dynavax Technologies (NASDAQ:DVAX) A Risky Investment?
Sep 12The Alphavaxers: Dynavax And Novavax, 2 Quarters On
Aug 22Dynavax up 8% after raising full-year guidance for key adjuvant product, Q2 beats
Aug 04Are Investors Undervaluing Dynavax Technologies Corporation (NASDAQ:DVAX) By 41%?
Jun 03Dynavax: Evolving Endemic Situation Adds To Its Risk
May 23Dynavax Technologies' (NASDAQ:DVAX) Performance Is Even Better Than Its Earnings Suggest
May 12Dynavax Technologies (NASDAQ:DVAX) Could Easily Take On More Debt
May 10Dynavax Technologies: Full Speed Ahead
Mar 01Here's Why Dynavax Technologies (NASDAQ:DVAX) Can Manage Its Debt Responsibly
Jan 28Dynavax: A Coronavirus Growth Story
Jan 17Is Dynavax Technologies Corporation (NASDAQ:DVAX) Expensive For A Reason? A Look At Its Intrinsic Value
Nov 18The Momentum Investor: Spotlight On Dynavax Technologies
Oct 25Dynavax And TLR Biology: Long-Delayed But Outstanding Success
Oct 16These 4 Measures Indicate That Dynavax Technologies (NASDAQ:DVAX) Is Using Debt Reasonably Well
Oct 02Analyse de la situation financière
Passif à court terme: Les actifs à court terme de DVAX ( $882.0M ) dépassent ses passifs à court terme ( $62.2M ).
Passif à long terme: Les actifs à court terme de DVAX ( $882.0M ) dépassent ses passifs à long terme ( $311.3M ).
Historique et analyse du ratio d'endettement
Niveau d'endettement: DVAX dispose de plus de liquidités que de sa dette totale.
Réduire la dette: Le ratio d'endettement de DVAX a été réduit de 1668.3% à 34.7% au cours des 5 dernières années.
Couverture de la dette: La dette de DVAX n'est pas bien couverte par le flux de trésorerie opérationnel ( 17.4% ).
Couverture des intérêts: Données insuffisantes pour déterminer si les paiements d'intérêts de DVAX sur sa dette sont bien couverts par l'EBIT.